Come hear from the current President of the Scripps Research Institute and Chairman of Pfizer’s Scientific Advisory Board (Lerner), and the founder of three biotechs (Winter), who together to helped make the antibody field the $30Billion market it is today.
With words from Susan Searle (CEO of Imperial Innovations), Sir Peter Lachmann, and Nature Biotech.
About the Oxbridge-London Biotech Roundtable
The Oxbridge-London Biotech Roundtable is a new fast growing student-led inter-campus and interdisciplinary forum connecting academics from across the UK with industry professionals to discuss topics in the life sciences and health care fields. We seek to bring young innovators together with the industry tools to move ideas forward.
Speakers
- Dr Richard Lerner is the current President of The Scripps Research Institute and discoverer of catalytic antibodies. He is the chairman of Pfizer’s scientific advisory board, serves on the boards of an additional four biotech companies, and has published over 400 research articles.
- Sir Greg Winter is a pioneer in antibody therapeutics and serial entrepreneur. His lab first humanized antibodies, work he commercialized as a founder of Bicycle Therapeutics, Domantis, and Cambridge Antibody Technology. He is currently Deputy Director of LMB at Cambridge.